| AE | Adverse Events |
| BMI | Body Mass Index |
| BSA | Bovine Serum Albumin |
| CR | Complete Response |
| CT | Computed Tomography |
| DAMP | Damage-Associated Molecular Pattern |
| DMSO | Dimethyl Sulfoxide |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| FIH | First in Human |
| IgG | Immunoglobulin G |
| LLL | Left Lower Lobe (lung anatomy) |
| LUL | Left Upper Lobe (lung anatomy) |
| MRI | Magnetic Resonance Imaging |
| mRECIST | Modified Response Evaluation Criteria in Solid Tumor |
| NSCLC | Non-Small Cell Lung Cancer |
| OD | Optical Density |
| PBMC | Peripheral Blood Mononuclear Cells |
| PBS | Phosphate-Buffered Saline |
| PEF | Pulsed Electric Field |
| PET-CT | Positron Emission Tomography-Computed Tomography |
| PD | Progressive Disease |
| PR | Partial Response |
| PTE population | Per-Treatment Evaluable population |
| RLL | Right Lower Lobe (lung anatomy) |
| RML | Right Medial Lobe (lung anatomy) |
| RUL | Right Upper Lobe (lung anatomy) |